Literature DB >> 17845472

Why Eberl is wrong. Reflections on the beginning of personhood.

Jan Deckers1.   

Abstract

In a paper published in Bioethics, Jason Eberl has argued that early embryos are not persons and should not be granted the status possessed by them. Eberl bases this position upon the following claims: (1) The early embryo has a passive potentiality for development into a person. (2) The early embryo has not established both 'unique genetic identity' and 'ongoing ontological identity', which are necessary conditions for ensoulment. (3) The early embryo has a low probability of developing into a more developed embryo. This paper examines these claims. I argue against (1) that a plausible view is that the early embryo has an active potentiality to grow into a more developed embryo. Against (2), I argue that neither 'unique genetic identity' nor 'ongoing ontological identity' are necessary conditions for ensoulment, and that 'ongoing ontological identity' is established between early embryos and more developed embryos. Against (3), I argue that the fact that the early embryo has a low probability of developing into a more developed embryo, if true, does not warrant the conclusion that the early embryo is not a person. If Eberl is right that the human soul is that which organises the activities of a human being and that ensouled humans are persons, embryos are persons from conception.

Entities:  

Mesh:

Year:  2007        PMID: 17845472     DOI: 10.1111/j.1467-8519.2007.00553.x

Source DB:  PubMed          Journal:  Bioethics        ISSN: 0269-9702            Impact factor:   1.898


  2 in total

1.  Can one be two? A synopsis of the twinning and personhood debate.

Authors:  Mark Rankin
Journal:  Monash Bioeth Rev       Date:  2013-09

2.  "So, what is an embryo?" A comparative study of the views of those asked to donate embryos for hESC research in the UK and Switzerland.

Authors:  Erica Haimes; Rouven Porz; Jackie Scully; Christoph Rehmann-Sutter
Journal:  New Genet Soc       Date:  2008-08-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.